健康网讯：

中印论坛：从医药大国到医药强国

第三届中印论坛将围绕如何从医药大国到医药强国的主题，针对中国制药的现状，在仿制药行业的政策法规及仿制药领域的热点、疑点展开一系列的对话，嘉宾来自中印两国医药领域相关的政府部门、行业协会及富有经验的领军企业。现场实时对话，帮您答疑解惑。请您提前预定坐席。

主办单位：中国化学制药工业协会

印度制药商协会

国药励展

会议时间：2012年11月8日 9:20–17:00

会议地点：厦门国际会展中心 305会议室

会议内容：

★ 9:20-9:30 协会嘉宾致欢迎辞

★9:30-10:30 仿制药的监督管理及相关问题

SFDA政策法规司相关负责人

内容简介：

针对仿制药监管领域的问题与热点，进行说明。

★ 10:30-11:30  印度：世界仿制药之都

Mr.Daara Patel 印度制药商协会秘书长

内容简介：

带您了解世界仿制药的最新资讯，印度仿制药领域的发展与现状。作为印度药品制造商协会，其会员750余家企业，成药产品占印度市场的75%，其权威、详实的报道将对行业发展有深远地影响。

★ 13:30-14:30 创建外向型医药企业

海正药业 副总 朱康秦

内容简介：

结合海正国际化遇到的问题与成果，分享海正多年发展外向型企业的经验。

★ 14:30-15:30 CGMP指导下的质量控制体系

Mr. S. M. Mudda,印度 MICRO LABS 公司执行总监

内容简介：

他山之石可以攻玉，Mr. S. M Mudda 在制药领域35年，对怎样进入国际市场，如何进行产品注册，怎样贯彻质量控制体系有着专业的见解。本次论坛以质量控制体系为基础，将带您一同了解印度企业的国际化过程。这将对国内企业如何参与国际市场竞争有着广泛的借鉴意义。

★    15:30-17:00 问答

3^rd Sino-India Forum: Turn a pharmaceutical power from major to strong in Xiamen on Nov 8, 2012

The Third Sino-India Forum focusing on how to turn a pharmaceutical power from major to strong. Leading speakers from SFDA, association and famous companies will deliver topics regarding regulatory affairs & generics, bring you the industry knowledge for both countries and open the gate to China and India Market. This is a party should not miss.

Organizers: China Pharmaceutical Industry Association (CPIA)
            Indian Drug Manufactures' Association (IDMA)

            Reed Sinopharm Exhibitions Co., Ltd.

Time: 9:20–17:00, Nov. 8th, 2012
Venue: Room 305, Xiamen International Conference & Exhibition Center

Contents：
★ 9:20-9:30
Address by CPIA & IDMA

★9:30-10:30
The regulatory affairs of China Pharmaceutical Industry
Officer of Dept of Policy and Regulations of SFDA
Focus on the generic drugs supervision of hot points, special questions.

★ 10:30-11:30
“INDIA: The Generics Pharma Capital of the World”
Mr Daara Patel Secretary General, IDMA
Bring the latest knowledge of the world generic industry, the development and current situation of Indian industry. More than 750 enterprises, take 75% of the entire India market.
The authentic report will effect the further development of the whole pharma industry.

Highlighting the global need for affordable quality generics from India – with more than 10,000 pharmaceutical manufacturers, Indian Pharma Industry holds the key to universal medicare

★ 13:30-14:30
How to establish export-oriented enterprises
VP Zhu Kangqin Hisun Pharmaceutcial
Based on the trouble and achievement of Hisun Pharmaceutical's internationalization, share the passed experiences to establish export-oriented enterprise.

★ 14:30-15:30 CGMP
Quality systems approach for CGMP implementation
Mr. S. M Mudda, Executive Director-Technical & Operations, MICRO LABS LTD.,
35 years' rich experience will tell you how to create quality manufacturing system for achieving current GMP standards

★ 15:30-17:00 Panel discussion.